Medicine
Olanzapine 10 mg powder for injection
Olanzapine 10 mg powder for injection is a generic prescription medicine for intramuscular use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
The USP defines controlled room temperature as a temperature maintained…
Key facts
- Active ingredient (INN)
- Olanzapine
- Brand
- Sold under the generic name
- Strength
- 10 mg
- Dosage form
- Powder for injection
- Route
- Intramuscular
- Packs
- 1 vial, 10 vials
- Manufacturer
- EugiaIndia
- Origin register
- US FDA, United States
- Storage
- The USP defines controlled room temperature as a temperature maintained thermostatically that encompasses the usual and customary working environment of 20° to 25°C (68° to 77°F), that results in a mean kinetic temperature calculated to be not more than 25°C, and that allows for excursions between 15° and 30°C (59° and 86°F) that are experienced in pharmacies, hospitals, and warehouses.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N05AH03 Olanzapine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 October 2020
- Identifiers
- RxCUI 485968DailyMed set ID 9c745e2e-89d3-44d4-906e-704705c33310NDC 55150-308Application ANDA210968
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-dose in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose | 55150-308-01 | EugiaIndia | 22 October 2020 |
| 10 vial, single-dose in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose | 55150-308-10 | EugiaIndia | 22 October 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Olanzapine
Clinical summary
Olanzapine is an atypical antipsychotic indicated for the treatment of schizophrenia, among other approved uses. It is available as tablets, orally disintegrating tablets and powder for injection for intramuscular and subcutaneous use. MedsAcross supplies Olanzapine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about OlanzapineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Zyprexa prescribing information (H2-Pharma) · U.S. National Library of Medicine, DailyMed
- Zypadhera: European public assessment report (EPAR) · European Medicines Agency
- Zyprexa Velotab: European public assessment report (EPAR) · European Medicines Agency
Need Olanzapine 10 mg powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.